Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) After Cardiac Surgery
Status:
Unknown status
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized controlled trial in patients undergoing cardiac surgery is to
show that a 3rd generation HES (Hydroxyethyl Starch) solution - Tetraspan® is as good as in
terms of safety and effectiveness as the commonly used albumin based solution for volume
replacement after the surgery.